Chlorofluorocarbon surfactants

A water-continuous emulsion, suitable for use as an antifoam additive, contains 85% to 98% by weight of a fluorosilicone oil and 2% to 15% by weight of an aqueous surfactant solution [1722]. The additive is suitable for use in separation of crude oil that contains associated gas. The additive may be used in both aqueous and nonaqueous systems and allows fluorosilicone oils to be used without the need for environmentally damaging chlorofluorocarbons. 

Hydrofluoric acid is used for manufacture of fluorocarbons, including fluoropolymers, chlorofluorocarbons chemical intermediates including fluoroborates, surfactants, herbicides, and electronic chemicals aqueous hydrofluoric acid petroleum alkylation and uranium processing. 

Until recently, only three chlorofluorocarbon (CFC) propellants, namely CFCs 11, 12 and 114 (Table 1), had been approved worldwide for use in medical MDIs. Their widespread acceptance was due to their ability to substantially meet the ideal propellant properties. All the CFC MDIs that are currently marketed employ CFC 12 as the major constituent mixed with either CFC 11 or with a mixture of CFC 11 and CFC 114. These mixtures of propellants closely obey Raoult s law and therefore the blend selected can be used to give a defined vapor pressure (Table 1). The inclusion of CFC 11 in the formulation also offered advantages in that it increased the solvency of most propellant systems, thereby facilitating the dissolution of surfactants in suspension formulations. By virtue of it being a liquid below 24° C, it was used as the primary dispersion medium for either suspending or dissolving the drug. 

As we have seen in Chapter 2, the formulation of a dmg in a chlorofluorocarbon cannot simply be reproduced with another propellant. Optimisation of vapour pressure, dmg stability, solubility and spray patterns must take place. Other ingredients of the formulation can include surfactants to act as solubilisers, stabilisers or lubricants to ease the passage the particles when emitted from the valve. 

The foam is prepared by adjusting the water content of the resin and adding a surfactant (eg, an ethoxylated nonionic), a blowing agent (eg, pentane, methylene chloride, or chlorofluorocarbon), and a catalyst (eg, toluenesulfonic acid or phenolsulfonic acid). The sulfonic acid catalyzes the reaction, while the exotherm causes the blowing agent, emulsified in the resin, to evaporate and expand the foam (121). The surfactant controls the cell size as well as the ratio of open-to-closed cell units. Both batch and continuous processes are employed. In the continuous process, the machinery is similar to that used for continuous polyurethane foam. 

---